Amgen Q3 Profit Beats Estimates; Lifts FY14 Guidance - Quick Facts

(RTTNews) - Amgen (AMGN) reported that its third-quarter net income decreased to $1.24 billion or $1.61 per share from $1.37 billion or $1.79 per share, last year. Amgen said its third-quarter was negatively impacted by pre-tax charges of $376 million for the restructuring plan announced earlier in the quarter. Adjusted net income was $1.77 billion or $2.30 per share, for the quarter.

On average, 20 analysts polled by Thomson Reuters expected the company to report profit per share of $2.11 for the quarter. Analysts' estimates typically exclude special items.

Total revenues increased to $5.03 billion from $4.75 billion, previous year. Analysts expected revenue of $4.96 billion for the quarter.

For the full year 2014, the company expects: total revenues to be in the range of $19.8 billion to $20.0 billion and adjusted EPS to be in the range of $8.45 to $8.55. Analysts expect the company to report full year profit per share of $8.42 on revenue of $19.73 billion.